Press releases

Month Year

Email alerts

Sep 13, 2016

Medtronic Foundation Issues $250,000 in Health Access Grants to Support Local Diabetes Services in Northridge, California

Medtronic Foundation Grants Support Organizations Committed

NORTHRIDGE, Calif. - Sept. 13, 2016 - Medtronic Foundation today announced that five community organizations will receive a combined $250,000 in Health Access Grants in recognition of their...
Sep 13, 2016

Medtronic Receives FDA Approval of First Drug-Coated Balloon for Treatment of In-Stent Restenosis (ISR)

IN.PACT Admiral DCB Indication Expansion to Treat Patients with ISR

DUBLIN - Sept. 13, 2016 - Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) approved the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) as a treatment...
Sep 12, 2016

New ESC Guidelines Support Recent Medtronic Innovations for Patients with Atrial Fibrillation

Clinical Practice Guidelines from European Society of Cardiology 2016 Reinforce Benefits of Cryoballoon Ablation and Long-Term Cardiac Monitoring

DUBLIN - September 12, 2016 - Two Medtronic plc (NYSE: MDT) innovations were acknowledged in updated guidelines published by the European Society of Cardiology (ESC): cryoballoon ablation for...
Sep 8, 2016

Medtronic Recognized as a Sustainability Leader

Company named to the Dow Jones Sustainability North America Index (DJSI North America)

DUBLIN - September 8, 2016 - Medtronic plc (NYSE: MDT) was recognized today as one of the world's leading companies for sustainability with its ranking on the Dow Jones Sustainability North...
Sep 6, 2016

Medtronic CEO Omar Ishrak to Speak at Morgan Stanley Global Healthcare Conference

DUBLIN - Sept. 6, 2016 - Medtronic plc (NYSE:MDT), a global leader in medical technology, services, and solutions, today announced that it will participate in the Morgan Stanley Global Healthcare...

Show per page

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa